Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001209191-20-024314

10% owner sold 564 shares at $2.66 ($1,500)

  • 10% owner acquired 1,500,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

New Enterprise Associates 16, L.P. · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-04-03 Option exercise : show line 1 in the form +1,500,000 $0.00 $1,500 5,938,562 D
2020-04-03 Sale : show line 2 in the form −564 $2.66 $1,500 5,937,998 D
Open-market sales · 564 sh · avg $2.66 · $1,500

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-04-03 Option exercise : show line 3 in the form Call Option (right to buy) −1,500,000 0 D
Loading xslF345X03/doc4.xml…